Skip to content
Accessibility help

Search NICE…

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (40)COVID-19 (33)

Type

TypeGuidance (5050)Indicators (320)News (388)NICE advice (496)Quality standards (256)Research recommendations (1785)

Status

StatusAwaiting development (398)Deferred (2)Discontinued (493)In consultation (15)In development (376)Published (2609)Topic prioritisation (384)

Last updated

Last updatedLast 3 months (242)Last 6 months (376)Last year (677)Last 3 years (1432)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (27)Antimicrobial resistance guidance (2)Cancer service guidelines (10)Clinical guidelines (389)COVID-19 rapid guidelines (27)Diagnostics guidance (138)Early value assessment (30)Health technology evaluations (43)HealthTech guidance (833)Highly specialised technologies guidance (49)Interventional procedures guidance (1597)Late stage assessment (8)Medical technologies guidance (207)Medicines practice guidelines (5)NICE guidelines (575)Public health guidelines (89)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2399)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (169)Medtech innovation briefings (324)NICE reviews (3)

Showing 2521 to 2535 of 9057 results

Sort by

MT658 Quit Genius for Smoking Cessation
Topic prioritisation
Result type
Medical technologies guidance
Status
Topic prioritisation
The Insides System chyme reinfusion system (MT682)
Topic prioritisation
Result type
Medical technologies guidance
Status
Topic prioritisation
Accuro handheld ultrasound device for locating intervertebral space for administration of spinal anaesthesia
Topic prioritisation
Result type
Medical technologies guidance
Status
Topic prioritisation
Remimazolam for general anaesthesia [ID3796]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Liposomal bupivacaine for treating postoperative pain [ID3799]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Remimazolam for sedation for people having diagnostic or therapeutic procedures [ID3758]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Crizotinib for treating ALK-positive anaplastic large cell lymphoma or inflammatory myofibroblastic tumour in people 6 to 17 years [TSID10574]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
TAK-880 for managing primary immunodeficiency diseases in people hypersensitive to IgA [TSID11883]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Insertion of Stoma Preservation Device
Topic prioritisation
Result type
Interventional procedures guidance
Status
Topic prioritisation
Subcutaneous efgartigmod for treating generalised myasthenia gravis [TSID11835]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) system for pancreatic cystic neoplasms and neuroendocrine tumours
Topic prioritisation
Result type
Interventional procedures guidance
Status
Topic prioritisation
Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in children 4 to 11 years [TSID12190]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation

Previous page
1
…
167
168
Current page 169
170
171
…
604
Page 169 of 604
Next page

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
BNF for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2026. All rights reserved. Subject to Notice of rights.